Stonebridge Capital Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
4,422
-100
| -2% | -$27.1K | 0.08% | 107 |
|
|
2025
Q4 | $1.13M | Hold |
4,522
| – | – | 0.08% | 109 |
|
|
2025
Q3 | $1.3M | Sell |
4,522
-25
| -0.5% | -$6.7K | 0.09% | 104 |
|
|
2025
Q2 | $1.19M | Sell |
4,547
-110
| -2% | -$26.8K | 0.09% | 104 |
|
|
2025
Q1 | $1.08M | Sell |
4,657
-25
| -0.5% | -$6.07K | 0.09% | 103 |
|
|
2024
Q4 | $1.07M | Hold |
4,682
| – | – | 0.09% | 110 |
|
|
2024
Q3 | $1.05M | Sell |
4,682
-45
| -1% | -$9.89K | 0.09% | 113 |
|
|
2024
Q2 | $962K | Sell |
4,727
-3,285
| -41% | -$668K | 0.08% | 114 |
|
|
2024
Q1 | $1.75M | Sell |
8,012
-3,172
| -28% | -$699K | 0.16% | 103 |
|
|
2023
Q4 | $2.54M | Sell |
11,184
-35
| -0.3% | -$7.35K | 0.26% | 79 |
|
|
2023
Q3 | $2.26M | Sell |
11,219
-1,911
| -15% | -$403K | 0.25% | 82 |
|
|
2023
Q2 | $2.72M | Sell |
13,130
-952
| -7% | -$185K | 0.29% | 76 |
|
|
2023
Q1 | $2.78M | Sell |
14,082
-206
| -1% | -$42.4K | 0.32% | 72 |
|
|
2022
Q4 | $2.89M | Sell |
14,288
-327
| -2% | -$63.9K | 0.34% | 69 |
|
|
2022
Q3 | $2.57M | Sell |
14,615
-451
| -3% | -$92.3K | 0.33% | 74 |
|
|
2022
Q2 | $3.03M | Sell |
15,066
-981
| -6% | -$209K | 0.37% | 72 |
|
|
2022
Q1 | $3.63M | Sell |
16,047
-392
| -2% | -$92.2K | 0.39% | 66 |
|
|
2021
Q4 | $4.44M | Buy |
16,439
+204
| +1% | +$50.5K | 0.49% | 60 |
|
|
2021
Q3 | $3.93M | Sell |
16,235
-20,504
| -56% | -$5.17M | 0.48% | 62 |
|
|
2021
Q2 | $8.38M | Buy |
36,739
+18,359
| +100% | +$4.18M | 0.53% | 64 |
|
|
2021
Q1 | $4.03M | Buy |
18,380
+160
| +0.9% | +$32.1K | 0.53% | 63 |
|
|
2020
Q4 | $3.19M | Sell |
18,220
-722
| -4% | -$125K | 0.48% | 65 |
|
|
2020
Q3 | $3.06M | Buy |
18,942
+202
| +1% | +$32K | 0.55% | 57 |
|
|
2020
Q2 | $2.67M | Sell |
18,740
-1,543
| -8% | -$213K | 0.5% | 62 |
|
|
2020
Q1 | $2.2M | Sell |
20,283
-1,245
| -6% | -$179K | 0.46% | 66 |
|
|
2019
Q4 | $3.13M | Sell |
21,528
-1,094
| -5% | -$158K | 0.51% | 64 |
|
|
2019
Q3 | $3.27M | Sell |
22,622
-926
| -4% | -$135K | 0.56% | 61 |
|
|
2019
Q2 | $3.5M | Sell |
23,548
-1,117
| -5% | -$156K | 0.62% | 57 |
|
|
2019
Q1 | $3.24M | Buy |
24,665
+1,175
| +5% | +$145K | 0.6% | 63 |
|
|
2018
Q4 | $2.55M | Sell |
23,490
-29
| -0.1% | -$3.88K | 0.59% | 58 |
|
|
2018
Q3 | $3.51M | Buy |
23,519
+478
| +2% | +$72.7K | 0.71% | 53 |
|
|
2018
Q2 | $3.55M | Buy |
23,041
+605
| +3% | +$91.3K | 0.77% | 53 |
|
|
2018
Q1 | $3.12M | Sell |
22,436
-64
| -0.3% | -$9.4K | 0.72% | 59 |
|
|
2017
Q4 | $3.08M | Sell |
22,500
-41
| -0.2% | -$5.42K | 0.71% | 57 |
|
|
2017
Q3 | $2.92M | Sell |
22,541
-570
| -2% | -$76K | 0.72% | 53 |
|
|
2017
Q2 | $3.06M | Buy |
23,111
+116
| +0.5% | +$14.2K | 0.8% | 52 |
|
|
2017
Q1 | $2.83M | Buy |
22,995
+105
| +0.5% | +$12.4K | 0.77% | 53 |
|
|
2016
Q4 | $2.52M | Sell |
22,890
-1,694
| -7% | -$188K | 0.75% | 53 |
|
|
2016
Q3 | $2.9M | Sell |
24,584
-355
| -1% | -$41.8K | 0.91% | 44 |
|
|
2016
Q2 | $2.79M | Buy |
24,939
+82
| +0.3% | +$8.82K | 0.95% | 40 |
|
|
2016
Q1 | $2.5M | Buy |
24,857
+960
| +4% | +$92K | 0.88% | 41 |
|
|
2015
Q4 | $2.54M | Buy |
23,897
+12,106
| +103% | +$1.25M | 0.93% | 39 |
|
|
2015
Q3 | $1.1M | Buy |
11,791
+1,094
| +10% | +$113K | 0.44% | 71 |
|
|
2015
Q2 | $1.11M | Sell |
10,697
-87
| -0.8% | -$9.06K | 0.43% | 74 |
|
|
2015
Q1 | $1.17M | Buy |
10,784
+98
| +0.9% | +$10.1K | 0.45% | 76 |
|
|
2014
Q4 | $991K | Buy |
10,686
+2,067
| +24% | +$183K | 0.41% | 79 |
|
|
2014
Q3 | $753K | Sell |
8,619
-524
| -6% | -$47.3K | 0.33% | 83 |
|
|
2014
Q2 | $804K | Sell |
9,143
-553
| -6% | -$47.9K | 0.36% | 84 |
|
|
2014
Q1 | $818K | Sell |
9,696
-757
| -7% | -$60.4K | 0.4% | 82 |
|
|
2013
Q4 | $821K | Buy |
+10,453
| New | +$892K | 0.42% | 80 |
|
Other funds holding LH
VCM
VPM
Stonebridge Capital Advisors's LH Position: Q1 2026 in Review
Stonebridge Capital Advisors reduced its Labcorp (LH) stake by 2.2% in Q1 2026, selling an estimated $27.1K and leaving 4,422 shares worth $1.18M. The position accounts for 0.08% of the portfolio, ranked #107.
Stonebridge Capital Advisors first reported a position in LH in Q4 2013 and has held it in 50 quarters since. The position peaked at $8.38M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Stonebridge Capital Advisors held 4,422 shares of Labcorp worth $1.18M as of Q1 2026.
- Stonebridge Capital Advisors sold 100 Labcorp shares in Q1 2026, an estimated $27.1K.
- Labcorp made up 0.08% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #107 holding.
- Stonebridge Capital Advisors first reported a position in Labcorp in Q4 2013 and has held it in 50 quarters since.
- Stonebridge Capital Advisors's Labcorp position peaked at $8.38M in Q2 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.